Рациональная фармакотерапия в кардиологии

Столичная издательская компания

Journal websitePeer review: Double-blind review
Evaluation status available after sign-in

About the journal

Рациональная фармакотерапия в кардиологии is an open-access journal published by Столичная издательская компания in Russia, publishing in russian and english. It is listed in DOAJ according to the sources read. Declared review time at DOAJ: 6 weeks. Facts are reproduced as recorded at their sources with their capture dates; PublishLens indicators are available after sign-in.

Basic facts

Publisher
Столичная издательская компания
ISSN
1819-6446 · 2225-3653
Country
Russia
Languages
russian, english
Access
Open access
Articles in DOAJ
3366
Declared review time
6 weeks
Declared peer-review model
double_blind

Index listings

  • DOAJ · 2012-06-12
Indexing
DOAJ
APC
—
Declared review time (DOAJ)
6 weeks — journal-declared only (not measured)
Activity (OpenAlex)
Active — latest works 2026
PublishLens list status
Shown after sign-in
Counts for promotion at your university?
Choose your university and rank below ↓

Methodology signals (dated facts from their sources)

Details of the evaluation under the published methodology are shown to signed-in users (free).

Create a free account to view the evaluation

Journal profile

Descriptive metadata from public sources (DOAJ, OpenAlex, PubMed) as of the capture date shown — contains no assessment or judgment.

Articles in DOAJ

3366

Most recent article

2 months ago

Average review time (journal-declared via DOAJ)

6weeks

Works in OpenAlex

2110

Last recorded publication year

2026

Reported by OpenAlex in 1 of 3 sources (CC0 flags, not verified indexing)DOAJSciELOOpenAlex Core

h-index

28

i10-index

129

From OpenAlex open data (CC0).

Editorial & policy9
Last DOAJ review date
2024-02-27
Added to DOAJ
2012-06-12
Declared plagiarism screening
Declared
Other fees beyond APC
Yes
Editorial board
Official page ↗
Norwegian register (HK-dir)— 2026
Level 1 — approved scholarly channel
Open references deposited at Crossref
98%
ORCID iDs in current deposits
98%
Deposits licence metadata at Crossref
✓
Peer-review policy
View policy
Identity & continuity2
Alternate titles
RFKRational pharmacotherapy in cardiology
Source type
journal
Classification4

Subjects (DOAJ)

Medicine: Therapeutics. PharmacologyMedicine: Internal medicine: Specialties of internal medicine: Diseases of the circulatory (Cardiovascular) system

LCC codes

RM1-950RC666-701

Subject areas

  • Healthcare Systems and Public Health
  • Healthcare Systems and Public Health
  • Blood Pressure and Hypertension Studies
  • Blood Pressure and Hypertension Studies
  • Atrial Fibrillation Management and Outcomes
  • Atrial Fibrillation Management and Outcomes
  • Neurological Disorders and Treatments
  • Neurological Disorders and Treatments
Show all subjects (50)
  • Lipoproteins and Cardiovascular Health
  • Lipoproteins and Cardiovascular Health
  • Acute Myocardial Infarction Research
  • Acute Myocardial Infarction Research
  • Cardiac Imaging and Diagnostics
  • Cardiac Imaging and Diagnostics
  • Antiplatelet Therapy and Cardiovascular Diseases
  • Antiplatelet Therapy and Cardiovascular Diseases
  • Human Health and Disease
  • Human Health and Disease
  • Heart Rate Variability and Autonomic Control
  • Cardiac Health and Mental Health
  • Heart Rate Variability and Autonomic Control
  • Cardiac Health and Mental Health
  • Cardiovascular Disease and Adiposity
  • Cardiovascular Disease and Adiposity
  • Venous Thromboembolism Diagnosis and Management
  • Venous Thromboembolism Diagnosis and Management
  • Cardiac Arrhythmias and Treatments
  • Cardiac Arrhythmias and Treatments
  • Cardiovascular Function and Risk Factors
  • Cardiac electrophysiology and arrhythmias
  • Cardiovascular Function and Risk Factors
  • Cardiac electrophysiology and arrhythmias
  • Hormonal Regulation and Hypertension
  • Hormonal Regulation and Hypertension
  • Pharmaceutical Economics and Policy
  • Pharmaceutical Economics and Policy
  • Cardiovascular Health and Disease Prevention
  • Cardiovascular Health and Disease Prevention
  • Health Systems, Economic Evaluations, Quality of Life
  • Heart Failure Treatment and Management
  • Heart Failure Treatment and Management
  • Health Systems, Economic Evaluations, Quality of Life
  • Cardiac, Anesthesia and Surgical Outcomes
  • Cardiac, Anesthesia and Surgical Outcomes
  • Eicosanoids and Hypertension Pharmacology
  • Eicosanoids and Hypertension Pharmacology
  • Sodium Intake and Health
  • Sodium Intake and Health
  • Pharmaceutical Practices and Patient Outcomes
  • Pharmaceutical Practices and Patient Outcomes

Keywords (DOAJ)

  • cardiology
  • diagnosis and treatment of heart disease
  • clinical pharmacology
  • pharmacotherapy
  • randomized clinical trials
  • cardiovascular risk factor

Community confirmations — what users saw in MJL or Scopus Sources; not platform verification and never part of any score.

Loading community confirmations…
How do we evaluate?Publisher of this journal? Appeal a derived assessment or request a factual correction

The journal's record in other sources:Web of Science MJLDOAJ

Everything shown here is produced automatically from named sources (DOAJ, OpenAlex, Crossref, PubMed, the Norwegian register) as of its capture date, with no human editing. Facts appear as recorded at the source; derived scores (PCI, PTD, PublishLens score) follow a published methodology. Not a judgement on the journal, not an official accreditation, not advice.

Wrong items are corrected automatically by re-reading the source (24 h for daily sources, 7 days for weekly ones) with a dated change log, and each item links to its source record. PublishLens-derived assessments are contested through the appeals mechanism (15 working days). Appeals · Indicator guide

Norwegian register data: Kanalregisteret (HK-dir, Norway) — CC BY 4.0 / NLOD — adapted: level extracted per year · OASPA member list — CC BY

Last automated source read: